BP000145-CYT-382: Recombinant Rat Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine CTLL-2 cells is 0.1-0.4 ug/ml corresponding to a specific activity of 2.5-10 MU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000144-CYT-203: Recombinant Human Interleukin-1 Receptor Antagonist Protein (IL-1RA)
Source: E. coli-derived.
The ED50 as determined by the dose-dependant inhibition of IL-1 stimulation of D10S cells was found to be 0.5 ug/ml corresponding to a Specific Activity of 2,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000144-CYT-658: Recombinant Mouse Interleukin-1 Receptor Antagonist Protein (IL-1RA) Protein
Source: E. coli-derived.
The mouse IL-1Ra is capable of inhibiting IL-1-alpha activity in helper T cell line D10.G4.1.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000144-CYT-481: Recombinant Human Interleukin-1 Receptor Antagonist Protein (IL-1RA), His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000143-CYT-411: Recombinant Mouse IL-19
Source: E. coli-derived.
The biological activity was determined by measuring the dose-dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a Specific Activity of 10,000 IU/mg of recombinant mouse IL-19.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000143-CYT-363: Recombinant Human IL-19
Source: E. coli-derived.
The activity is determined by it's ability to activate STAT following receptor-ligand interaction.
Purity > 99%, by SDS-PAGE and RP-HPLC.BP000142-CYT-663: Recombinant Human IL-18, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000142-CYT-376: Recombinant Rat IL-18
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of IFN-gamma by murine lymph node cells (400,000 cells/well) co-stimulated with sub optimal dose of ConA (0.75 ug/ml) is 12 ug/ml corresponding to a specific activity of 84,000 U/mg. The medium was RPMI containing 10% FCS and 50 2-ME.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000142-CYT-634: Recombinant Mouse IL-18
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.BP000142-CYT-269: Recombinant Human IL-18
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the IFN-g by human PBMC co-stimulated with IL-12 was found to be 5 ug/ml corresponding to a Specific Activity of 200,000 IU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.